This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Huazhong University of Science and Technology, Tongji Hospital, Tongji Medical College. Active years: 2012.
Company Filing History:
1 out of 528 
1 out of 1 
1 out of 2 Years Active: 2012
Title: Daowen Wang: Innovator in Gene Therapy
Introduction
Daowen Wang is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of gene therapy, particularly through his innovative work on recombinant adeno-associated viruses.
Latest Patents
Wang holds a patent for a recombinant adeno-associated virus expressing the human antisense gene CYP2J2 and its preparation methods. This patent describes a method of co-transfection into 293 cells using calcium phosphate precipitation. The recombinant adeno-associated virus (rAAV) is produced with three specific plasmids, which enhance the expression of the gene significantly.
Career Highlights
Throughout his career, Daowen Wang has worked at notable institutions such as Tongji Hospital and Huazhong University of Science and Technology. His work has focused on advancing the understanding and application of gene therapy techniques.
Collaborations
Wang has collaborated with esteemed colleagues, including Xiao Xiao and Jiangang Jiang, contributing to various research projects and advancements in the field.
Conclusion
Daowen Wang's innovative work in gene therapy, particularly through his patent on recombinant adeno-associated viruses, showcases his commitment to advancing medical science. His contributions continue to influence the field and inspire future research.